EPA targets microplastics and pharmaceuticals in drinking water

Key Points:

• The EPA proposed adding microplastics and pharmaceuticals to its Contaminant Candidate List for drinking water, marking the first time these substances are considered for potential regulation under the Safe Drinking Water Act.
• EPA Administrator Lee Zeldin emphasized responding to public concerns about plastics and pharmaceuticals in drinking water, aligning with Health Secretary Robert F. Kennedy Jr.'s MAHA movement, which advocates for stricter environmental contaminant controls.
• The proposal opens a 60-day public comment period, with finalization expected by mid-November; however, experts note that inclusion on the list often does not lead to immediate regulatory action.
• Kennedy announced a $144 million initiative, STOMP, aimed at detecting, understanding, and removing microplastics from human bodies, underscoring the health risks associated with these contaminants.
• While environmental groups view the EPA's move as a positive first step, some criticize the agency for previous regulatory rollbacks and call for stronger actions, including monitoring and limits on microplastics and plastic production.